Stacy S. Shord, PharmD, BCOP, FCCP, is the Deputy Director in the Division of Cancer Pharmacology II in the Office of Clinical Pharmacology within U.S. Food and Drug Administration. Dr. Shord received her Doctor of Pharmacy from University of Maryland School of Pharmacy in 1997. She then completed a Pharmacy Practice residency at the University of Pittsburgh Medical Center, an Oncology Pharmacy Practice residency at UNC Hospitals, and a fellowship in Oncology Pharmacotherapy at the UNC Eshelman School of Pharmacy.
Dr. Shord joined the faculty at the University of Illinois at Chicago College of Pharmacy in 2001 as an assistant professor where her research focused on drug metabolism in patients with cancer and hematological diseases. She joined the Food and Drug Administration in 2009 and served as a primary reviewer and Lead Pharmacologist in the Office of Clinical Pharmacology and an Associate Director of Labeling in the Office of Oncologic Diseases. Special interests include labeling and pediatric drug development. Dr. Shord earned her Board Certification in Oncology Pharmacy in 2000. She has authored more than 50 peer reviewed papers and 10 book chapters. Dr. Shord is a member of ASCPT, ASCO, ACCP and HOPA.